drugset / Trial / NCT05332405

SPY Angiography To Assist With Ulnar Nerve Transposition at the Elbow

NCT05332405

Phase 4 Withdrawn NYU Langone Health
NaSingle-groupOpen-labelTreatment

Summary

Patients with vascular disease, thyroid disease or an allergy to indocyanine green (ICG) will be excluded. Patients with either median or ulnar nerve compression will be treated with nerve decompression. SPY angiography will be used to assess the vascularity of the nerve both pre and post release as the primary outcome measure.

Timeline

Start
2022-05-26
Primary completion
2023-10-01
Completion
2024-04-01

Drugs

EvaluationDrugModalityDoseRoute
Background Indocyanine Green Diagnostic / imaging agent 3 ml Intravenous